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Abstract
Background: Of the thirteen active carbonic anhydrase (CA) isozymes, CA IX and XII have been
linked to carcinogenesis. It has been suggested that these membrane-bound CAs participate in
cancer cell invasion, which is facilitated by an acidic tumor cell environment. Since active cell
migration is a characteristic feature of embryonic development, we set out to explore whether
these isozymes are expressed in mouse embryos of different ages. The studies were focused on
organogenesis stage.
Results: Immunohistochemistry demonstrated that both CA IX and XII are present in several
tissues of the developing mouse embryo during organogenesis. Staining for CA IX revealed a
relatively wide distribution pattern with moderate signals in the brain, lung, pancreas and liver and
weak signals in the kidney and stomach. The expression pattern of CA XII in the embryonic tissues
was also relatively broad, although the intensity of immunostaining was weak in most tissues. The
CA XII-positive tissues included the brain, where the most prominent staining was seen in the
choroid plexus, and the stomach, pancreas, liver and kidney.
Conclusion: Membrane-bound CA isozymes IX and XII are expressed in various tissues during
mouse organogenesis. These enzymes may regulate ion and pH homeostasis within the developing
embryo.
Background
The carbonic anhydrases (CAs) are a group of zinc-contain-
ing metalloenzymes that catalyse the reversible hydration of
carbon dioxide in a reaction CO2 + H2O ↔ H+ + HCO3 -. They
are produced in a variety of tissues, where they play impor-
tant roles in a number of biological processes such as acid-
base balance, respiration, carbon dioxide and ion transport,
bone resorption, ureagenesis, gluconeogenesis, lipogenesis
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active alpha CAs have been reported in mammals so far, of
which CA I, II, III, VII, and XIII are cytoplasmic [4], CA IV, IX,
XII, XIV, and XV are anchored to plasma membranes [5-8],
CA VA and VB are mitochondrial [9], and CA VI is the only
secretory form, present in saliva and milk [10,11].
Of the thirteen active isozymes, CA IX and XII have been
linked to neoplastic invasion [12,13]. Both are transmem-
brane proteins. CA IX is composed of four domains: an N-ter-
minal proteoglycan domain, a CA catalytic domain, a
transmembrane region and a short cytoplasmic tail [14]. It is
a highly active enzyme, and its activity can be efficiently
inhibited by sulfonamides [15-19]. In addition to its enzyme
activity and role in pH control, CA IX is a cell adhesion mol-
ecule and may also contribute to cell proliferation [20-22].
The distribution of CA IX has been studied in adult human,
rat and mouse tissues [5,23]. The most abundant expression
of CA IX was observed in the human alimentary tract, partic-
ularly in the mucosa of the stomach and gallbladder, and it
was also detected in the ileum, colon, liver and pancreas. In
mouse tissues, the highest immunoreactivity for CA IX was
reported in the gastric mucosa, while moderate signals were
also seen in the colon and brain and lower expression in
some other tissues, including the pancreas and various seg-
ments of the small intestine. CA IX is ectopically expressed at
relatively high levels and with a high prevalence in some
tumor tissues whose normal counterparts do not contain this
protein, e.g. carcinomas of the cervix uteri, esophagus, kid-
ney, lung and breast [24-29]. On the other hand, tumors
originating from tissues with high natural CA IX expression,
such as the stomach and gallbladder, often lose some or all
of their CA IX upon conversion to carcinomas [30-32].
CA XII contains an N-terminal extracellular domain, a
putative transmembrane α-helix and a small intracellular
C-terminal segment with potential phosphorylation sites
[6,14,33]. Its expression has been demonstrated by
immunohistochemistry in the adult human kidney,
colon, prostate, pancreas, ovary, testis, lung and brain
[34,35], and the enzyme has been localized to the basola-
teral plasma membranes of the epithelial cells [36-38]. In
the human kidney, CA XII is confined to the proximal and
distal tubules and the principal cells of the collecting duct
[39]. In mouse tissues it is most abundant in the kidney
[40] and the surface epithelial cells of the colon [41]. CA
XII expression also shows a clear association with certain
tumors, being overexpressed in renal cancer cells, for
example [6].
One characteristic feature of embryonic development is
active cell migration from one place to another. Although
this clearly represents a benign process, it has some mech-
anistic similarities to cancer cell invasion [42,43], e.g. the
fact that the moving cells invade through the extracellular
matrix. Since CA IX and XII probably participate in neo-
plastic invasion, we set out to explore how these isozymes
are expressed during embryonic development.
Results and discussion
Immunohistochemical staining of CA IX revealed a rela-
tively wide distribution pattern, although the signal inten-
sity most often remained low or moderate. The E7.5
embryos, representing a gastrulation stage, were com-
pletely negative (Figure 1). CA IX expression in the various
tissues during organogenesis is summarized in Table 1.
The protein was present in the developing brain at all ages
Immunostaining of CA IX and CA XII in the embryos at E7.5Figure 1
Immunostaining of CA IX and CA XII in the embryos at E7.5. No immunoreaction is detected for either CA IX (A) or CA XII 
(B). Original magnifications: × 400.Page 2 of 9
(page number not for citation purposes)
BMC Developmental Biology 2006, 6:22 http://www.biomedcentral.com/1471-213X/6/22studied (Figure 2). The brain tissue was stained moder-
ately, and some positivity was occasionally observed in
cells present in the mesenchyme beneath the developing
brain (data not shown). Moderate staining was also seen
in the nerve ganglia and choroid plexus (Figure 2). No
immunoreaction for CA IX was detected in the kidney at
E11.5, whereas a weak positive signal appeared at E12.5
(Figure 3). The developing pancreas showed a moderate
positive reaction at E12.5, which was primarily seen in the
basolateral plasma membrane and intracellular compart-
ment of the epithelial cells (Figure 4). Weak staining for
CA IX was present in the stomach at all ages studied (Fig-
ure 5). This is in accordance with the finding that CA IX is
functionally important for a normal gastric histological
structure [44]. The liver also showed positive immunos-
taining in scattered cells (Figure 5). Positive labeling was
seen in the lung and heart, tissues not expressing the pro-
tein in the adult mouse (data not shown). It is notable,
however, that the adult heart tissue also gave a slight pos-
itive signal with the automated immunostaining method,
even though it has been previously considered negative
for CA IX [23].
The expression pattern of CA XII in embryonic tissues was
also relatively broad, although the staining intensity was
weak in most tissues. The E7.5 embryos showed no
immunoreaction (Figure 1). Results at later stages are
summarized in Table 2. CA XII protein was expressed in
the brain and nerve ganglia at every subsequent age dur-
ing organogenesis (Figure 2), most prominently in the
choroid plexus at E12.5 and E13.5 (Figure 2), i.e. at the
time when the developing choroid plexus usually
becomes visible. Interestingly, a weak signal for CA XII
was detected in several embryonic tissues, including the
stomach (Figure 5), pancreas (Figure 4) and liver (Figure
5), which are all negative in adult mice [41]. No staining
was detected in the stomach at E11.5, while a weak posi-
tive signal appeared there at E12.5. The liver showed weak
or moderate staining for CA XII during organogenesis. It
is notable that even though CA XII is highly expressed in
the adult mouse kidney, the embryonic kidney showed
only a weak signal (Figure 3). Weak immunostaining was
also seen in the pancreas, where just a few of the develop-
ing ducts were positive (Figure 4). In the heart, the stain-
ing became stronger during mouse development (data not
shown), but as with CA IX, the specificity of CA XII immu-
nostaining is questionable in this particular organ. How-
ever, the control stainings using normal rabbit serum
instead of the anti-CA IX or anti-CA XII serum gave no
positive signals.
CA IX and XII are distinct CA isozymes in that they are
overexpressed in certain tumors and subjected to regula-
tion by the von Hippel Lindau tumor suppressor protein/
hypoxia pathway [35,45]. In developing embryo, the
expression patterns of CA IX and CA XII may also be
related to the presence of hypoxia, which is considered
essential for proper morphogenesis of various tissues [46].
Hypoxia appears important particularly for development
of the brain, myocardial vascularization, lung branching
morphogenesis, formation of mesoderm and establish-
ment of various progenitor cells [47-49].
The high catalytic activities of CA IX and XII support their
role in acidification of the tumor microenvironment,
which in turn facilitates the migration of tumor cells
through the extracellular matrix [12,13]. The question is
whether CA IX and XII also participate in cell migration
during embryonic development. Although the present
results provide no functional evidence that CA IX or XII is
involved in cell migration during embryogenesis, they do
indicate that several cell types in the mouse embryo
express these isozymes. Interestingly, both isozymes were
present though at quite low level in some embryonic tis-
sues whose adult counterparts do not express these partic-
ular proteins or the expression is very low. These findings
contrast with prior studies on the developmental regula-
tion of CA IV. This isozyme, like many of the cytosolic iso-
zymes, is expressed at much lower levels in most tissues of
the embryo than are found in the adult [50,51].
Conclusion
Membrane-bound CA isozymes IX and XII are expressed
in several tissues of developing mouse embryo. As mem-
brane-bound CAs with an extracellular active site, CA IX
and XII represent key enzymes in the maintenance of an
appropriate pH in the extracellular milieu. Future studies
should therefore be focused on exploring how strictly pH
homeostasis is regulated in a developing embryo and
what are the possible structural or functional conse-
quences if this homeostasis is disrupted.
Table 1: Distribution of CA IX in mouse embryonic tissues of 
different age.*
Organ E11.5 E12.5 E13.5
Brain ++ ++ ++
Heart (ventricle/atrium) +/++ ++/++ +/++
Lung ND ++ +
Kidney - + +
Pancreas ND ++ ND
Liver + ++ ++
Stomach + + +
Intestine + ++ +
* Scores in immunohistochemistry: strong reaction (+++), moderate 
reaction (++), weak reaction (+), no reaction (-), not done (ND).Page 3 of 9
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Immunostaining of CA IX and CA XII in embryonic and adult mouse nervous tissuesFigure 2
Immunostaining of CA IX and CA XII in embryonic and adult mouse nervous tissues. All embryos are aged E12.5 except the 
choroid plexus for CA XII, which is aged E13.5. CA IX shows moderate staining in the embryonic brain (A), with the signal 
mainly located in the neurons. CA IX is also present in the trigeminal ganglion (B) and the choroid plexus (C). Panel G shows 
strong positive staining for CA IX in the adult brain. CA XII gives weak staining in the embryonic brain (D), but panel E shows 
moderate staining in the trigeminal ganglion. The strongest immunoreaction is located in the chroid plexus (F). No specific sig-
nal for CA XII is detectable in the adult brain (H) except for the choroid plexus (data not shown). Control immunostaining of 
the embryonic brain with normal rabbit serum is negative (I). Manual PAP staining in panels A-E and I, automated immunostain-
ing in panels F-H. Original magnifications: A-E, I × 400, F × 630, G-H × 200.
BMC Developmental Biology 2006, 6:22 http://www.biomedcentral.com/1471-213X/6/22Methods
Antibodies
Polyclonal rabbit antibodies to mouse CA IX and CA XII
have been described earlier [40,44]. Non-immune normal
rabbit serum (NRS) was used in the control stainings
instead of the specific antisera.
Immunohistochemistry
Mouse embryos were obtained by mating male and
female NMRI mice. The procedures were approved by the
animal care committees of Helsinki University and Tam-
pere University. Noon on the day on which the copula-
tion plug was found was considered to represent 0.5 days
Immunostaining of CA IX and CA XII in the kidney of E12.5 mouse embryos and in the adult mouse kidneyFigure 3
Immunostaining of CA IX and CA XII in the kidney of E12.5 mouse embryos and in the adult mouse kidney. Both CA IX (A) 
and CA XII (B) show weak staining in the ductal epithelium of the embryonic tissue, and a positive immunoreaction is seen for 
both isozymes in the adult mouse renal tubules (C, D), with CA XII also located in the collecting ducts. Control immunostain-
ing of an adult mouse kidney with NRS gave no positive signal (E). Manual PAP staining in panels A-B and E, automated immu-
nostaining in panels C-D. Original magnifications: A-B × 400, C-E × 100.Page 5 of 9
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BMC Developmental Biology 2006, 6:22 http://www.biomedcentral.com/1471-213X/6/22p.c. 7.5 (n = 2), 11.5 (n = 3), 12.5 (n = 4) and 13.5 (n = 2)
p.c. embryos with or without extraembryonic tissues were
briefly washed with PBS, fixed with 4% paraformaldehyde
and embedded in paraffin. Sections were cut at 5–8 μm
and placed on SuperFrost® Plus microscope slides (Men-
zel; Braunschweig, Germany). Tissue samples from the
stomach, heart, brain, liver, kidney and pancreas of an
adult NMRI mouse were obtained for control purposes.
Immunoperoxidase staining was performed using an
automated Lab Vision Autostainer 480 (ImmunoVision
Technologies Co., Brisbane, CA, USA). As this automated
immunostaining method produced some nonspecific
Immunostaining of CA IX and CA XII in the embryonic (E12.5) and adult mouse pancreasFigure 4
Immunostaining of CA IX and CA XII in the embryonic (E12.5) and adult mouse pancreas. The reaction for CA IX is moderate 
in the embryonic tissue, with the most intense staining in the epithelial cells (A). CA XII gives weak staining in the epithelium 
(B). A quite strong but focal signal is seen for CA IX in the acinar cells of the adult pancreas (C), while no immunoreaction is 
detected for CA XII (D). The control immunostaining of the mouse embryonic pancreas is negative (E). Manual PAP staining in 
panels A-B and E, automated immunostaining in panels C-D. Original magnifications: A-B, E × 400, C-D × 100.Page 6 of 9
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BMC Developmental Biology 2006, 6:22 http://www.biomedcentral.com/1471-213X/6/22labeling of the nuclei in the embryonal tissues, immunos-
taining was repeated using a less sensitive but more spe-
cific peroxidase-antiperoxidase complex method (manual
PAP) to confirm the validity of the results.
The automated immunostaining, performed using Power
Vision+™ Poly-HRP IHC Kit (ImmunoVision Technolo-
gies, Co.) reagents, included the following steps: (a) rins-
ing in wash buffer; (b) treatment in 3% H2O2 in ddH2O
for 5 min and rinsing in wash buffer; (c) blocking with
Universal IHC Blocking/Diluent for 30 min and rinsing in
wash buffer; (d) incubation with the primary antibody
(rabbit anti-mouse CA IX or XII) or NRS diluted 1:2000 in
Universal IHC Blocking/Diluent for 30 min; (e) rinsing in
wash buffer for 3 × 5 min; (f) incubation in poly-HRP-
conjugated anti-rabbit IgG for 30 min and rinsing in wash
buffer for 3 × 5 min; (g) incubation in DAB (3,3' -diami-
nobenzidine tetrahydrochloride) solution (one drop of
DAB solution A and one drop of DAB solution B in 1 ml)
ddH2O for 6 min; (h) rinsing with ddH2O ; (i) CuSO4
treatment for 5 min to enhance the signal; and (j) rinsing
with ddH2O. All procedures were carried out at room tem-
perature. The sections were mounted in Entellan Neu
(Merck; Darmstadt, Germany) and finally examined and
photographed with a Zeiss Axioskop 40 microscope (Carl
Zeiss; Göttingen, Germany).
Immunostaining of CA IX and CA XII in the embryonic (E12.5) mouse stomach and liverFigure 5
Immunostaining of CA IX and CA XII in the embryonic (E12.5) mouse stomach and liver. Both CA IX (A) and CA XII (B) show 
weak immunoreaction in the stomach (CA XII barely detectable). CA IX gives moderate staining in the liver, the signal being 
seen in scattered cells (C). Panel D shows a weak positive signal of CA XII in the liver (D). Manual PAP staining in panels A-D. 
Original magnifications: × 400.Page 7 of 9
(page number not for citation purposes)
BMC Developmental Biology 2006, 6:22 http://www.biomedcentral.com/1471-213X/6/22The immunostaining by the PAP method included the fol-
lowing steps: (a) 3% H2O2 in methanol for 5 min and
washing in PBS for 5 min; (b) treatment with undiluted
cow colostral whey (Biotop) for 30 min and rinsing in
PBS; (c) incubation with the primary antibody (rabbit
anti-mouse CA IX or XII) diluted 1:100 in 1% bovine
serum albumin (BSA) in PBS for 1 hr and washing in PBS
3 times for 10 min; (d) treatment with undiluted cow
colostral whey for 30 min and rinsing in PBS; (e) incuba-
tion with the secondary antibody (swine anti-rabbit IgG;
DAKO, Glostrup, Denmark) diluted 1:100 in 1% BSA in
PBS for 1 hr and washing in PBS 3 times for 10 min; (f)
incubation with peroxidase-antiperoxidase complex
(PAP-rabbit; DAKO) diluted 1:100 in PBS for 30 min and
washing in PBS 4 times for 5 min; and (g) incubation for
2 1/2 min in DAB solution (6 mg 3,3' -diaminobenzidine
tetrahydrochloride; Sigma, St Louis, MO) in 10 ml PBS
plus 3,3 μl 30% H2O2. All incubations and washings were
carried out at room temperature. The sections were
mounted in Entellan Neu (Merck; Darmstadt, Germany)
and finally examined and photographed with a Zeiss Axi-
oskop 40 microscope.
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